ClinicalTrials.Veeva

Menu

Liver Function Abnormalities in Patients With Acute Heart Failure

S

Sohag University

Status

Not yet enrolling

Conditions

Acute Heart Failure

Treatments

Behavioral: Avoiding the risk factors

Study type

Observational

Funder types

Other

Identifiers

NCT06491628
LFTs abnormalities in AHF

Details and patient eligibility

About

The aim of this study is to evaluate liver function test abnormalities and to identify associated cardiac and non cardiac factors mediating hepatic impairment in acute heart failure patients

Full description

Cardiac failure has a negative impact on the function of all parenchymatous organs, based both on the low organ perfusion in the left-sided failure and on the venous congestion in the right-sided failure.

The pathophysiology of acute heart failure (AHF) is complex and not fully understood. It has been hypothesized that an episode of acute decompensation affects not only the cardiovascular system itself, but may also deteriorate the function of other organs, c ausing serious clinical consequences. Liver involvement has been mostly described and investigated in patients with chronic HF.

Liver enzyme alterations are usually classified as relating predominantly to liver cell necrosis (signified by transaminase elevations) or predominantly to cholestasis (signified by elevated alkaline phosphatase (AP) level).

Enrollment

100 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients aged 18 yrs or older presenting with AHF

Exclusion criteria

  • Congenital heart disease
  • acute and chronic liver diseases

Trial design

100 participants in 5 patient groups

Acute decompensated heart failure (de novo or as decompensation of chronic heart failure)
Description:
This umbrella term includes patients presenting forthe first time with typical symptoms and signs of heart failure(de novo AHF) and also those with worsening of their pre-existing cardiomyopathy (acute decompensated heart failure).
Treatment:
Behavioral: Avoiding the risk factors
Pulmonary edema
Description:
It's the real clinical presentation of AHF, typically, signs and symptoms develope rapidly and patients demonstrate severe respiratory distress with tachypnea, orthopnea and pulmonary congestion
Treatment:
Behavioral: Avoiding the risk factors
Hypertensive acute heart failure
Description:
the condition is associated with elevated blood pressure with accompanying dyspnea. orthopnea and pulmonary congestion, often in patients with relatively preserved left ventricle ejection fraction
Treatment:
Behavioral: Avoiding the risk factors
cardiogenic shock
Description:
severe peripheral hypoperfusion wih subsequent end organs damage,typically it's associated with low blood pressure and low urine output
Treatment:
Behavioral: Avoiding the risk factors
Acute coronary syndrome complicated by heart failure
Description:
characterized by complex structural, hemodynamic and neurohormonal interaction need urgent referral for coronary intervention poor outcome
Treatment:
Behavioral: Avoiding the risk factors

Trial contacts and locations

1

Loading...

Central trial contact

Sara Mohamed; Hassan Ahmed

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems